Charlene Crisp, MD
Family Medicine · Westerville, OHNPI 1558514794
Payments from drug & device makers
Across 244 payments — averaging $14.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$750
- AbbVie$683
- Novo Nordisk$488
- Pfizer$434
- Lilly USA, LLC$248
- Amarin Pharma, Inc.$188
- plus $799 from 18 others
What the payments were for
- Food & beverage$3,589100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 51 | $750 |
| AbbVie(2 entities) | 47 | $683 |
| Novo Nordisk | 35 | $488 |
| Pfizer | 25 | $434 |
| Lilly USA, LLC | 16 | $248 |
| Amarin Pharma, Inc. | 17 | $188 |
| Abbott | 7 | $127 |
| Amgen | 7 | $98 |
| Merck | 7 | $93 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $57 |
| GSK | 3 | $56 |
| Kowa Pharmaceuticals America, Inc. | 4 | $53 |
| Teva Pharmaceuticals USA, Inc. | 3 | $47 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $41 |
| Biohaven Pharmaceuticals, Inc. | 3 | $40 |
| Astellas Pharma US Inc | 2 | $38 |
| Boehringer Ingelheim | 2 | $33 |
| Sanofi-aventis U.S. LLC | 2 | $31 |
| Bayer | 1 | $22 |
| Xeris Pharmaceuticals, Inc. | 1 | $15 |
| Currax Pharmaceuticals LLC | 1 | $12 |
| Novartis | 1 | $12 |
| Shire North American Group Inc | 1 | $12 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $11 |
How this compares
$3,589 in reported general payments places this provider in the 80th percentile of 3,983 family medicine providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Potassium Chloride | 13 | $250 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 13 | $237 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 37 | $221 |
| Losartan Potassium | 13 | $156 |
| Enalapril Maleate | 11 | $136 |
| Metoprolol Succinate | 18 | $105 |
| Atorvastatin Calcium | 19 | $103 |
| Levothyroxine Sodium | 13 | $95 |
| Cephalexin | 25 | $72 |
| Pantoprazole Sodium | 14 | $54 |
| Doxycycline Hyclate | 14 | $48 |
| Prednisone | 39 | $47 |
| Azithromycin | 18 | $40 |
| Lisinopril | 11 | $25 |
| Furosemide | 17 | $17 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Westerville
- Michael ButcherCincinnati$18.3M
- William RandallKettering$7.5M
- Paul NugentCincinnati$4.9M
- Steve ChoiDayton$4.8M
- Martin SchearDayton$2.2M
- Rajesh DavitCincinnati$2M
- Kwabena OtengSpringdale$2M
- Blaise GattoMoraine$1.8M
- Cathy GreiweColumbus$1.4M
- Brian BeesleyColumbus$1.4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.